(35.172.224.102)
Users online: 2183    [ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2017, Volume : 10, Issue : 5
First page : ( 1477) Last page : ( 1480)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2017.00260.8

Epigallocatechin Gallate Attenuates Behavioral Defects in Sodium Valproate Induced Autism Rat Model

Kumaravel P.1,*, Melchias G.2, Vasanth N.2, Manivasagam T.3

1Department of Biotechnology, St. Joseph's College (Autonomous), Tiruchirappalli, Tamil Nadu, India

2Department of Botany, St. Joseph's College (Autonomous), Tiruchirappalli, Tamil Nadu, India

3Department of Biochemistry and Biotechnology, Annamalai University, Chidambaram, Tamil Nadu, India

*Corresponding Author E-mail: kumaravelbiotech@gmail.com

Online published on 17 July, 2017.

Abstract

Pregnant rats were administered by either sodium valproate (VPA) with 250 mg/kg during fetal neural tube development on embryonic day 12, induces neural tube defects and impairment in behaviors related to autistic spectrum disorder in newborns, which make it a useful animal model of autism. Male rat pups were subjected to behavioral testing to assess exploratory activity, peripheral and central movements and motor activity like grooming and rearing on postnatal day 90. We investigated the role of EGCG (2mg/kg) in reversing cardinal behavioral changes induced by VPA exposed rats. Consumption of EGCG has been associated with neuronal protection against the impact of toxicants. EGCG exerts neuronal cytoprotective action possibly due to antioxidant action and neuroprotective effect could be efficacious in the management of autism.

Top

Keywords

Autism, VPA, EGCG, Behavior.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
596,768,681 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.